Web Results

en.wikipedia.org/wiki/Bruesewitz_v._Wyeth

Bruesewitz v. Wyeth, 562 U.S. 223 (2011), is a United States Supreme Court case that decided whether a section of the National Childhood Vaccine Injury Act of 1986 preempts all vaccine design defect claims against vaccine manufacturers . Contents. [hide]. 1 Background; 2 Decision; 3 See also; 4 References; 5 External ...

caselaw.findlaw.com/us-supreme-court/09-152.html

United States Supreme Court. BRUESEWITZ ET AL. v. WYETH LLC, FKA WYETH, INC., ET AL., (2011). No. 09-152. Argued: October 12, 2010 Decided: February 22, 2011. The National Childhood Vaccine Injury Act of 1986 (NCVIA or Act) created a no-fault compensation program to stabilize a vaccine market adversely ...

www.law.cornell.edu/supct/cert/09-152

Oct 12, 2010 ... After their daughter suffered severe health problems following a routine vaccination for diphtheria-tetanus-pertussis (“DTP”), Russell and Robalee Bruesewitz sued Wyeth, Inc., the manufacturer of the vaccine, alleging that Wyeth's DTP vaccine was outmoded and inadequately designed. In response, Wyeth ...

www.natlawreview.com/article/perdue-v-wyeth-pharmaceuticals-inc-triple-knockout-pre-emption-and-innovator

Sep 9, 2016 ... See Sara Perdue, as Executor of the Estate of Marjorie Newton v. Wyeth Pharmaceuticals, Inc., et al., Civil Action No. 4:15-cv-00208-FL, 2016 U.S. Dist. LEXIS 94636 (E.D.N.C. Jul. 20, 2016). Amiodarone/Cordarone® is a prescription medication approved by the FDA as a treatment of last resort for ...

howappealing.abovethelaw.com/SimonVsWyethReplyBriefForAppellantFinal.pdf

v. WYETH PHARMACEUTICALS, INC., et al.,. Defendants. No. 2620 EDA 2007: Appeal of plaintiff Merle Simon;. No. 2673 EDA 2007: Cross–appeal of defendant Pharmacia & Upjohn Co., LLC. REPLY BRIEF FOR APPELLANT/. RESPONSE BRIEF FOR CROSS–APPELLEE. On Appeal from the Judgment of the Court of ...

www.mwe.com/en/thought-leadership/newsletters/2015/10/anda-update-october-2015

Accordingly, these kinds of settlements are subject to the rule of reason. King Drug Company of Florence, Inc. v. SmithKline Beecham Corp., et al., 791 F.3d 388 (3d Cir. 2015). Background. In earlier Paragraph IV litigation, Teva had challenged the validity and enforceability of GSK's patent on lamotrigine, Lamictal's active ...

www.kirkland.com/sitecontent.cfm?contentID=220&itemID=8017

Professional Profile. Doug Smith has litigated cases at both the trial and appellate stage in state and federal courts throughout the country, including commercial, mass tort, product liability, securities, bankruptcy, environmental, and intellectual property cases. He is a member of the American Law Institute and has published ...

www.killworthlaw.com/trial-testimony-services-dayton-oh.html

2) Louis J. McDermott, II Iv. OmidInternational, Columbus, Ohio (1988) (for defendant-accused infringer) (Judge Graham) ... 9) Nitec, Inc. v. Sievers Instruments, Inc., Houston, Texas (1996) (for plaintiff-patentee) (Judge Gilmore) 10) Reroof America et al. v. United Structures of America, Inc., Tulsa, Oklahoma ( 1997) (for ...

www.contractormisconduct.org/misconduct

Merck & Co., Inc. $1,857,395. 9/4/2013, Puerto Rico v. Shell Oil Co., et al. (MTBE Groundwater Contamination) ChevronTexaco Corporation, Exxon Mobil, Royal Dutch Shell PLC, $0. 9/4/2007, Bridge Medical Stockholder Lawsuit AmerisourceBergen, $26,900,000. 9/30/2016, China Subsidiary Bribery Investigation